Apmonia Therapeutics

French tech company | Builders Republic

About

Biotech developing first-in-class peptide therapeutics that target the tumor's surrounding environment — lead candidate is a cyclic peptide that reprograms the blood vessels feeding tumors and reactivates the immune system's anti-tumor response in ovarian and colorectal cancer.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2019
City
REIMS
Region
Grand Est
Tracked rounds
1
Amount raised
10 M€ raised since 2020

Funding rounds

  • Series A — 2026

Investors